Literature DB >> 11777733

Huntington's disease: a review of the literature on prevalence and treatment of neuropsychiatric phenomena.

P Naarding1, H P Kremer, F G Zitman.   

Abstract

A review was made of the literature on Huntington's disease, including the clinical neurology, recent advances in pathophysiology and genetic mechanisms and psychopathology. It can be concluded that research on the latter is scarce, although the subject is relevant because of the co-occurrence of psychiatric, neurological and genetic phenomena, which may lead to novel concepts in the understanding of brain function. So far, attempts to provide a comprehensive and pragmatic description of the psychopathology of Huntington's disease have been disappointing, probably due to the limitations of the DSM classification system in this disorder. Future research should focus not only on this classification system, but also on neuropsychological functioning, because of the degenerative nature of the disease. Systematic and controlled studies should be performed on the treatment of psychiatric abnormalities in Huntington's disease before any conclusions can be drawn.

Entities:  

Mesh:

Year:  2001        PMID: 11777733     DOI: 10.1016/s0924-9338(01)00604-6

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  21 in total

Review 1.  Chorea and related disorders.

Authors:  R Bhidayasiri; D D Truong
Journal:  Postgrad Med J       Date:  2004-09       Impact factor: 2.401

2.  Longitudinal behavioral, cross-sectional transcriptional and histopathological characterization of a knock-in mouse model of Huntington's disease with 140 CAG repeats.

Authors:  Aaron C Rising; Jia Xu; Aaron Carlson; Vincent V Napoli; Eileen M Denovan-Wright; Ronald J Mandel
Journal:  Exp Neurol       Date:  2010-12-28       Impact factor: 5.330

3.  Validation of Neuro-QoL and PROMIS Mental Health Patient Reported Outcome Measures in Persons with Huntington Disease.

Authors:  Noelle E Carlozzi; Siera Goodnight; Anna L Kratz; Julie C Stout; Michael K McCormack; Jane S Paulsen; Nicholas R Boileau; David Cella; Rebecca E Ready
Journal:  J Huntingtons Dis       Date:  2019

4.  Behavioral Changes in Huntington Disease

Authors:  Jason Brandt
Journal:  Cogn Behav Neurol       Date:  2018-03       Impact factor: 1.600

5.  Patterns of serotonergic antidepressant usage in prodromal Huntington disease.

Authors:  Kelly C Rowe; Jane S Paulsen; Douglas R Langbehn; Chiachi Wang; James Mills; Leigh J Beglinger; Megan M Smith; Eric A Epping; Jess G Fiedorowicz; Kevin Duff; Adam Ruggle; David J Moser
Journal:  Psychiatry Res       Date:  2012-03-05       Impact factor: 3.222

6.  Not on the face alone: perception of contextualized face expressions in Huntington's disease.

Authors:  Hillel Aviezer; Shlomo Bentin; Ran R Hassin; Wendy S Meschino; Jeanne Kennedy; Sonya Grewal; Sherali Esmail; Sharon Cohen; Morris Moscovitch
Journal:  Brain       Date:  2009-05-18       Impact factor: 13.501

7.  Cognitive, anxiety and mood disorders in the fragile X-associated tremor/ataxia syndrome.

Authors:  James A Bourgeois; Jennifer B Cogswell; David Hessl; Lin Zhang; Michele Y Ono; Flora Tassone; Faraz Farzin; James A Brunberg; Jim Grigsby; Randi J Hagerman
Journal:  Gen Hosp Psychiatry       Date:  2007 Jul-Aug       Impact factor: 3.238

8.  Patient and caregiver quality of life in Huntington's disease.

Authors:  Rebecca E Ready; Melissa Mathews; Anne Leserman; Jane S Paulsen
Journal:  Mov Disord       Date:  2008-04-15       Impact factor: 10.338

Review 9.  Latrepirdine, a potential novel treatment for Alzheimer's disease and Huntington's chorea.

Authors:  Marwan N Sabbagh; Holly A Shill
Journal:  Curr Opin Investig Drugs       Date:  2010-01

10.  Responsiveness to change over time and test-retest reliability of the PROMIS and Neuro-QoL mental health measures in persons with Huntington disease (HD).

Authors:  Noelle E Carlozzi; Nicholas R Boileau; Matthew W Roché; Rebecca E Ready; Joel S Perlmutter; Kelvin L Chou; Stacey K Barton; Michael K McCormack; Julie C Stout; David Cella; Jennifer A Miner; Jane S Paulsen
Journal:  Qual Life Res       Date:  2020-08-19       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.